Blue Owl Capital Inc. Class A Common Stock vs Rocket Lab USA Inc — how do they compare? Blue Owl Capital Inc. Class A Common Stock trades at $8.8 (market cap $6.01B), while Rocket Lab USA Inc trades at $52.91 (market cap $37.84B). The key difference: Rocket Lab USA Inc is far larger — about 6.3× Blue Owl Capital Inc. Class A Common Stock's market cap, and Blue Owl Capital Inc. Class A Common Stock pays a 10.35% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Blue Owl Capital Inc. Class A Common Stock for 0 Days and Rocket Lab USA Inc for 29 Days on average.
| OWL | RKLB | |
|---|---|---|
Market Cap | $6.01B | $37.84B |
Volume | 24,327,195 | 24,121,394 |
Sector | Financials | Industrials |
52-Week High | $17.17 | $150.23 |
52-Week Low | $8.23 | $39.48 |
Typical Hold Time | 0 Days | 29 Days |
Enterprise Value | $10.19B | $35.67B |
Dividend Yield | 10.35% | — |
Signals from Pluang's Aura AI — not financial advice
Blue Owl Capital (OWL) trades at $9.29, down 0.54% on the day, with neutral technical indicators showing support at $9 and resistance at $10. The company reported mixed quarterly earnings, beating expectations in Q4 2025 and Q2 2026 but missing in Q1 2026, with Q3 2026 results pending. Revenue growth remains steady at $2.9B in 2025, projected to $3.0B in 2026, though net margins are thin at 2.71%. Analyst sentiment is positive with 63% buy ratings and a $11.01 consensus target, but private credit fund redemptions and loan quality concerns present headwinds.
OWL offers value at a discount to analyst targets with strong institutional backing, but investors face risks from high P/E valuation (77.42), exposure to private credit volatility, and competitive pressures. The stock's 9.8% dividend yield and embedded fee growth from $31.1B in committed capital support upside, though execution on portfolio quality and redemption management will dictate near-term performance. Neutral outlook with cautious optimism pending Q3 earnings clarity.
Rocket Lab (RKLB) trades at $64.22, down 2.27% amid bearish technical signals despite recent positive business developments. The company secured its largest-ever commercial Electron deal with Synspective, expanding its launch backlog to over 100 missions. Fundamentally, RKLB shows strong revenue growth but remains unprofitable with negative margins, trading at elevated valuation multiples. Analyst sentiment remains overwhelmingly bullish with a $107 consensus price target representing significant upside potential.
The investment case balances strong growth prospects against persistent profitability challenges. While the expanding launch backlog and recent contract wins support long-term growth, the company faces execution risks amid intense competition and cash burn. Technical indicators suggest near-term weakness, but analyst consensus points to substantial upside if RKLB can achieve profitability milestones.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Blue Owl Capital Inc. is an alternative asset manager that invests across credit, real assets, and GP strategic capital strategies, providing private capital solutions to businesses and to institutional and individual investors.
Read more on OWL →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →